Medite Cancer Diagnostics Inc (MDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,811 | -2,163 | -859 | -699 | 54 |
| Depreciation Amortization | 482 | 234 | 177 | 170 | 202 |
| Income taxes - deferred | 492 | N/A | 78 | 80 | -33 |
| Accounts receivable | 589 | 314 | 113 | -594 | -141 |
| Accounts payable and accrued liabilities | -75 | 557 | N/A | -110 | -106 |
| Other Working Capital | 1,888 | 129 | 136 | -444 | -627 |
| Other Operating Activity | -134 | -162 | -33 | 706 | 247 |
| Operating Cash Flow | $-3,569 | $-1,091 | $-388 | $-891 | $-404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -134 | -115 | -208 | -463 | -95 |
| Net Acquisitions | N/A | N/A | N/A | 1 | N/A |
| Other Investing Activity | 0 | 0 | -146 | 0 | 0 |
| Investing Cash Flow | $-134 | $-115 | $-354 | $-462 | $-95 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -5 | 81 | N/A | N/A | N/A |
| Debt Issued | 4,985 | 150 | 500 | N/A | 644 |
| Debt Repayment | -2,812 | 135 | -802 | -162 | -210 |
| Common Stock Issued | 2,344 | 406 | 2,054 | 1,979 | N/A |
| Other Financing Activity | -1,047 | -72 | -40 | -113 | 0 |
| Financing Cash Flow | $3,465 | $700 | $1,712 | $1,704 | $434 |
| Exchange Rate Effect | 203 | 27 | -613 | -196 | 75 |
| Beginning Cash Position | 108 | 587 | 230 | 75 | 65 |
| End Cash Position | 73 | 108 | 587 | 230 | 75 |
| Net Cash Flow | $-35 | $-479 | $357 | $155 | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,569 | -1,091 | -388 | -891 | -404 |
| Capital Expenditure | -134 | -115 | -208 | -463 | -95 |
| Free Cash Flow | -3,703 | -1,206 | -596 | -1,354 | -499 |